These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9777517)

  • 1. Antibiotic resistance among clinically important gram-positive bacteria in the UK.
    Johnson AP
    J Hosp Infect; 1998 Sep; 40(1):17-26. PubMed ID: 9777517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance in gram-positive bacteria: epidemiological aspects.
    Witte W
    J Antimicrob Chemother; 1999 Sep; 44 Suppl A():1-9. PubMed ID: 10511391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update on antibiotic resistance in Gram-positive bacteria].
    Lozano C; Torres C
    Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():2-8. PubMed ID: 28129816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
    Rubinstein E; Bompart F
    J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies for management of resistant Gram-positive infections: from S. pneumoniae to MRSA].
    Cristini F
    Infez Med; 2007 Sep; 15 Suppl 2():13-9. PubMed ID: 17940408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
    Casellas JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections caused by Gram-positive bacteria: a review of the global challenge.
    Woodford N; Livermore DM
    J Infect; 2009 Sep; 59 Suppl 1():S4-16. PubMed ID: 19766888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin resistance: occurrence, mechanisms and strategies to combat it.
    Boneca IG; Chiosis G
    Expert Opin Ther Targets; 2003 Jun; 7(3):311-28. PubMed ID: 12783569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the spread of antibiotic-resistant bacteria.
    Rao GG
    Drugs; 1998 Mar; 55(3):323-30. PubMed ID: 9530540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.
    Rivera AM; Boucher HW
    Mayo Clin Proc; 2011 Dec; 86(12):1230-43. PubMed ID: 22134942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Manfredi R
    Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant gram-positive organisms.
    Schaberg DR
    Ann Emerg Med; 1994 Sep; 24(3):462-4. PubMed ID: 8080144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
    Michel M; Gutmann L
    Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
    Severina E; Severin A; Tomasz A
    J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance. Nosocomial gram-positive infection.
    Cookson B; Morrison D; Marples R
    J Med Microbiol; 1997 Jun; 46(6):439-42. PubMed ID: 9379468
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel agents for resistant Gram-positive infections--a review.
    Strahilevitz J; Rubinstein E
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S38-46. PubMed ID: 12044288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
    Ross JE; Fritsche TR; Sader HS; Jones RN
    Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.